local_hospital

Vaestra Goetalandsregionen

Address
lock Available on a paid plan

Psychiatry and Psychology: Behavioral Disciplines and Activities

At Vastraa Goetalandsregionen, the Dep of Pediatrics is contributing to clinical research in Psychiatry and Psychology with a focus on behavioral disciplines and related mental health conditions in children, adolescents, and adults. The studies are centered on evaluating new or existing treatments and understanding their effects on symptoms and day-to-day functioning.

  • Research in ADHD is examining the safety and effectiveness of treatment options for children and adolescents who cannot use stimulant medicines.
  • One key goal is to better understand how therapy may support attention, psychomotor speed, and overall cognitive performance.
  • The site is also involved in work on schizophrenia spectrum disorder, looking at whether an immune-based treatment can improve psychiatric symptoms.

This area of research reflects a strong interest in improving care for mental disorders through studies that assess treatment benefit, symptom change, and longer-term patient outcomes.

Mental Disorders: ADHD and Schizophrenia Spectrum Disorder

The clinical trials at this hospital/clinic in Goteborg are focused on two major mental health conditions: attention-deficit/hyperactivity disorder and schizophrenia spectrum disorder. The research aims to compare treatment options, monitor safety, and explore whether therapies can improve everyday functioning and clinical symptoms.

  • In ADHD, the trials are testing treatment effectiveness and long-term safety in younger patients.
  • In schizophrenia spectrum disorder, the studies are evaluating whether a targeted therapy may reduce psychotic symptoms more effectively than placebo.
  • These projects support better treatment selection for patients with complex psychiatric needs.

Overall, the research combines psychiatric care and clinical evaluation to help determine which approaches may offer the greatest benefit for patients.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
6
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
2
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 188 other sites in Sweden

description
Trial volume
2
Outperforms 41% of sites
public
Therapeutic diversity
2areas
Outperforms 41% of sites
groups
Sponsor diversity
2sponsors
Outperforms 41% of sites

Therapeutic Area Benchmark — Sweden

Select a therapeutic area to compare against other sites in Sweden.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Sweden

Market Share

Country: Sweden

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Vaestra Goetalandsregionen

lock Showing 1 of 2 trials — the rest is available on a paid plan.

IMP list

lock Showing 1 of 6 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Atomoxetine Hydrochloride1Unknown2019-11-202019-11-20

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.